Search the Newsreel

OraSure wins FDA emergency nod for Ebola test (OSUR:NASDAQ)

OraSure Technologies (OSUR) has received Emergency Use Authorization from the FDA for its second-generation Ebola test, OraQuick Ebola 2.0. This test is designed to detect the virus in both living patients and deceased individuals suspected of having died from the disease. The authorization will …

OraSure receives Emergency Use Authorization for second generation Ebola test

OraSure Technologies has received Emergency Use Authorization from the FDA for its second-generation OraQuick Ebola 2.0 Rapid Antigen Test. This new test can detect all four known Ebola viruses and can be used on living patients' blood or oral fluids from those suspected to …

Why Has OraSure Technologies (NASDAQ:OSUR) Entered Nasdaq News?

OraSure Technologies (NASDAQ:OSUR) has garnered attention due to a recent market-cycle update focusing on public health readiness, rapid diagnostics, and broader diagnostic testing trends. The article notes that the company is in focus because it received emergency authorization for a second-generation Ebola test. It …

OraSure (OSUR) Secures FDA Approval for Enhanced Ebola Rapid Tes

OraSure Technologies Inc. (OSUR) has received FDA Emergency Use Authorization for its OraQuick Ebola 2.0 Rapid Antigen Test, which can detect all four human-affecting Ebola strains in both living patients and post-mortem samples. This advancement is significant for timely diagnosis and outbreak control, especially …

OraSure Technologies Gets Emergency Use Authorization From FDA for New Ebola Test

OraSure Technologies has received Emergency Use Authorization (EUA) from the FDA for its new OraQuick Ebola 2.0 Rapid Antigen Test. This second-generation test offers increased sensitivity and can detect all four known Ebola viruses in live patients through whole blood and in cadaveric oral …

Canadian fund manager trims Orosur Mining voting stake below 10%

Orosur Mining updates warrant block listing, 5.38M securities allotted

Why Aroa Biosurgery (ASX:ARX) Shares Are Under Pressure Today

Aroa Biosurgery Delivers $104 Million Revenue and Second Consecutive Positive EBITDA in FY26 Breakout Year

Aroa Biosurgery Ltd Actuals & Estimates (ASX:ARX)

Aroa Biosurgery (ASX:ARX): Medical Device Stock Slides as Investors Watch Expansion Plans

A Look At Aroa Biosurgery’s Valuation After Its Profit Turnaround In Full Year 2026 Results

Aroa Biosurgery (ASX:ARX) TTM Profitability Emerges

ASX Penny Stocks Spotlight Aroa Biosurgery And Two More Top Picks

Why Aroa Biosurgery’s (ASX:ARX) EBITDA Turnaround Is Catching Investor Attention

Aroa Biosurgery Sets Ambitious FY27 Targets after Exceeding FY26 Guidance

Orosur Mining Expands Share Capital Following RSU Exercises by Directors and Consultants (OMI)

OraSure Announces First Quarter 2026 Financial Results

OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th

Orosur Mining shares rise 19% after new gold zone discovered near Pepas deposit in Colombia

Analysts Expect Breakeven For Aroa Biosurgery Limited (ASX:ARX) Before Long

Orosur Mining Stock Slides: Hidden Opportunity or Red Flag?

Canaccord sees upside in Aroa Biosurgery

Orosur Mining reports maiden resource at Pepas, shares dip

Orosur Mining shares up on exploration update

Aroa Biosurgery Limited (ASX:ARX) Just Reported Interim Earnings: Have Analysts Changed Their Mind On The Stock?

While institutions own 32% of Aroa Biosurgery Limited (ASX:ARX), individual investors are its largest shareholders with 42% ownership

Insights: Aroa Biosurgery Ltd (ASX:ARX)

OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Are Pretty Bullish On The Stock After Recent Results

OROSUR MINING INC (OMI.NE) Stock Price, News, Quote & History

Orosur Mining Inc Share Price - OMI, RNS News, Articles, Quotes, & Charts (LON:OMI)